Skip to content

Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anteriorly

Perfluorooctyl Bromideessential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05699096
Enrollment
20
Registered
2023-01-26
Start date
2024-09-01
Completion date
2026-07-01
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Disease

Brief summary

Perfluorohexyloctaneis Essential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

Interventions

None listed

Sponsors

EL Romany Ophthalmics Factory
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* \- Is 20 years or older Has been diagnosed with Keratoconus; Has no other active ocular disease; Is not pregnant or nursing;

Exclusion criteria

* Is under the age of 20 Has best corrected visual acuity outside 20/400; Pregnant or nursing at the time of enrollment in the study;

Design outcomes

Primary

MeasureTime frameDescription
flat the detached retina and displace the underneath fluids anteriorlyBase linethe effect of Perfluorooctyl Bromide on the retina ,under ophthalmic microscope check the flatted retina

Countries

Egypt

Contacts

Primary ContactEl R Ophthalmics
drmina@elromanyophthalmics.com+201212331343

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026